EyeControl
EyeControl is an Israel-based medical device company that builds AI-assisted eye-tracking headsets and bedside communication software enabling intubated, sedated, and ALS patients to communicate, serving hospitals and ICUs via enterprise subscriptions and home patients via Ministry of Health-subsidized distribution.
- Company typePrivate
- Founded2016
- HeadquartersTel Aviv, Israel
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What EyeControl does
EyeControl (legally Eyefree Assisting Communication Ltd.) is an Israel-based medical device company founded in 2016 that builds an adaptive communication platform combining specialized hardware and software for patients who cannot speak due to intubation, sedation, or neurological conditions such as ALS. The platform consists of a wearable headset that pairs bone conduction audio with an AI-assisted infrared eye-tracking camera, a bedside tablet hub that delivers interventions under sedation and supports active engagement during recovery, and a secure Family App for message, photo, and music sharing. The system requires no calibration, supports multilingual communication including cross-language input/output, and operates 24/7 with seamless sleep-mode transitions.
The company operates two distinct go-to-market motions. For hospitals and ICUs, EyeControl sells a platform subscription/licensing model with on-the-ground Clinical Product Specialists handling implementation, training, and adoption at the bedside. Named enterprise customers include major Israeli hospitals (Rabin/Beilinson, Assuta, Meir, Tel Aviv Sourasky, PIC), all four major Israeli HMOs (Clalit, Maccabi, Meuhedet, Leumit), and in the United States, Northwell Health. For ALS and degenerative-disease patients at home, the EyeControl Home product is distributed via field specialists and is fully subsidized by Israel's Ministry of Health, removing patient cost.
The business generates revenue from healthcare-facility subscriptions and from hardware sales (the headset and bedside tablet). EyeControl holds FDA 21 CFR Part 11 clearance, ISO 27001, HIPAA, and GDPR compliance, and has raised approximately $15.3M across disclosed rounds from investors including Connecticut Innovations, the European Innovation Council, BIRD Foundation, Menomadin Foundation, and ZORA Ventures.
EyeControl firmographics
Firmographics- Name
- EyeControl
- Legal name
- Eyefree Assisting Communication Ltd.
- Website
- https://eyecontrol.co.il
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EyeControl is an Israel-based medical device company that builds AI-assisted eye-tracking headsets and bedside communication software enabling intubated, sedated, and ALS patients to communicate, serving hospitals and ICUs via enterprise subscriptions and home patients via Ministry of Health-subsidized distribution.
- Ownership category
- akta.pro rank
EyeControl industry classification
Industry- Product category
- Medical Communication Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Computer Peripheral Equipment, Nec (3577)
- akta.pro primary industry
- Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards) (HDACAFAL)
- akta.pro secondary industry
- Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount) (HDACALAH)
Keywords
Where EyeControl is headquartered
LocationHeadquarters
- HQ city
- Tel Aviv
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
EyeControl business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Healthcare Facility Licenses/Subscriptions: Platform licensing or subscription model to hospitals and healthcare facilities for ICU and critical care communication support
- EyeControl Home (Consumer/Home Health): Direct-to-patient home communication solution for ALS patients, subsidized by Israel's Ministry of Health
- Hardware (Headset): Specialized headset device combining bone conduction audio with eye-tracking technology
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | EyeControl Home - Ministry of Health Subsidized |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
EyeControl product offering
Product offeringCore offering
EyeControl develops an adaptive communication platform combining specialized wearable hardware (a headset with bone conduction audio and AI-powered infrared eye-tracking camera) with bedside tablet and family mobile app software. The platform enables patients who cannot speak due to intubation, sedation, ALS, or other neurological conditions to communicate through eye gestures, scan audio-based menus, and connect with medical teams and families across ICU/critical care and home environments.
Product overview
EyeControl offers a unified adaptive communication platform designed for critical care and home use. The platform consists of specialized hardware components (Headset with bone conduction audio and AI-powered eye tracking, Bedside Tablet) and software (Family App) that work together to enable patients with complex needs to communicate. EyeControl Home extends the solution for home use by ALS patients. The platform supports patients from sedation through rehabilitation, providing 24/7 assistance with personalized and adaptable interaction modes.
Differentiator
Problem solved
Functional benefit
Brands
- EyeControl Home: Communication solution for patients with ALS and other degenerative diseases, fully subsidized by the Ministry of Health.
Products and services
- EyeControl Platform An adaptive communication platform combining specialized hardware (headset with bone conduction audio and AI-powered eye tracking, bedside tablet) and software (Family App) that supports patients from sedation through rehabilitation across hospital and home environments. Designed for ICU/critical care teams and patients with complex communication needs.
- EyeControl Headset A wearable FDA-cleared medical device combining bone conduction audio with an infrared eye-tracking camera to detect patient awareness and enable hands-free communication responses through eye gestures for sedated, intubated, or neurologically impaired patients.
- EyeControl Bedside Tablet
Quantifiable outcome
- Reduces ICU patient agitation through calming input and communication
- +3 more outcomes
Companies that use EyeControl
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles2 records
EyeControl technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature8 records
EyeControl partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Ministry of Health (Israel)coreIsraeli government health ministry subsidizes EyeControl Home solution for ALS patients, making it free for qualifying patients
- HCA HealthcareminorAdvisory board member Karen H. Thompson serves as AVP of Regional Community Engagement at HCA Healthcare
- Baylor University Medical CenterminorAdvisory board member Dr. Ariel Modrykamien serves at Medical ICU of Baylor University Medical Center
- Tel Aviv Sourasky Medical CenterminorAdvisory board member Prof. Vivian Drory is a neurologist at Tel Aviv Sourasky Medical Center
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
EyeControl competitors and assessment
Company assessmentBroad incumbents
- Vocera Communications (Stryker): Vocera (acquired by Stryker) provides secure hands-free clinical communication and alarm management for hospitals, including ICU workflows. Broad incumbent in hospital clinical communication with overlapping ICU patient/staff communication use cases, though not focused on eye-tracking-based patient output.
- Hillrom / Baxter Patient Communication: Baxter (after acquiring Hillrom/Voalte) offers Voalte and Hillrom bedside communication platforms deployed in hospitals. Broad incumbent in hospital patient/staff communication infrastructure with overlapping ICU and patient-engagement applications.
- Tobii AB (Tech division): Tobii AB, the parent of Tobii Dynavox, develops eye-tracking hardware and platforms across healthcare, research, and consumer applications. Comparable as an enabling technology supplier and broader eye-tracking presence.
Direct peers
- EyeTech Digital Systems: EyeTech Digital Systems manufactures eye-tracking hardware and AAC integration solutions used in assistive communication and clinical research. Direct overlap in eye-tracking component technology for communication applications.
- PRC-Saltillo: PRC-Saltillo (Prentke Romich Company / Saltillo) sells AAC devices including eye-tracking-based communicators (e.g., Accent 1000 with NuEye) for individuals with speech disabilities. Directly comparable to EyeControl in providing eye-gaze AAC solutions to non-speaking patients.
- Lingraphica: Lingraphica provides AAC devices and apps primarily for adults with aphasia and other communication disorders, often reimbursed through US insurance. Comparable in delivering speech-generating devices to non-verbal adult populations.
- Tobii Dynavox: Tobii Dynavox is the dominant dedicated AAC (augmentative and alternative communication) vendor using eye-tracking hardware (Tobii eye trackers) and dedicated software for non-speaking individuals with ALS, cerebral palsy, and other conditions. It is the most direct competitor to EyeControl on assistive eye-tracking communication.
- Smartbox Assistive Technology: Smartbox (Grid/Communicator product line) builds AAC hardware and software, including eye-gaze-enabled devices for people with complex communication needs. Highly comparable in target population and modality.
- LC Technologies: LC Technologies (Eyegaze Edge) builds eye-tracking-based AAC systems for non-verbal users including those with ALS and locked-in syndrome. Direct peer in eye-gaze communication hardware and software.
Emerging players
- AssistiveWare: AssistiveWare produces Proloquo and Keeble AAC software, primarily on iPad, focused on autism, cerebral palsy, and progressive conditions. Less hardware-specialized than EyeControl but addresses a similar communication-needs population with iOS-based tools.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
EyeControl social profiles
Digital presenceEyeControl compliance and trust
Trust signalCompliance4 records
EyeControl financial estimates
Financial estimateRevenue estimate
Valuation estimate
EyeControl leadership team
Management profileNumber of profiles
Profiles1 record
EyeControl funding detail
Funding detailFunding overview
Funding rounds8 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EyeControl M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EyeControl
What does EyeControl do?
EyeControl develops an adaptive communication platform combining specialized wearable hardware (a headset with bone conduction audio and AI-powered infrared eye-tracking camera) with bedside tablet and family mobile app software. The platform enables patients who cannot speak due to intubation, sedation, ALS, or other neurological conditions to communicate through eye gestures, scan audio-based menus, and connect with medical teams and families across ICU/critical care and home environments.
Is EyeControl a public or private company?
EyeControl is a private company. It is classified as venture growth investor backed and is currently operating.
When was EyeControl founded?
EyeControl was founded in 2016. It employs 11 to 50 people.
Where is EyeControl based?
EyeControl is headquartered in Tel Aviv, Israel, in the Middle East region.
How does EyeControl make money?
Three revenue lines are on record. Healthcare Facility Licenses/Subscriptions are the primary driver. The others are eyeControl Home (Consumer/Home Health) and hardware (Headset).
Who are EyeControl's main competitors?
Broad incumbents on record are Vocera Communications (Stryker), Hillrom / Baxter Patient Communication and Tobii AB (Tech division). Direct peers are EyeTech Digital Systems, PRC-Saltillo, Lingraphica, Tobii Dynavox, Smartbox Assistive Technology and LC Technologies. AssistiveWare is listed as an emerging player.
Does EyeControl have an API?
No public API is recorded for EyeControl.
What industry is EyeControl in?
EyeControl's product category is Medical Communication Devices. Its primary akta.pro industry code is HDACAFAL, Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards), with a secondary code of HDACALAH, Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount). Its NAICS code is 334510 and its SIC code is 3845.